Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127220911 | 12722091 | 1 | I | 20160831 | 20160907 | 20160907 | EXP | US-MYLANLABS-2016M1037590 | MYLAN | BUEHNER M, PAMPLIN J, STUDER L, HUGHES RL, KING BT, GRAYBILL JC, ET AL. OXALATE NEPHROPATHY AFTER CONTINUOUS INFUSION OF HIGH-DOSE VITAMIN C AS AN ADJUNCT TO BURN RESUSCITATION. J-BURN-CARE-RES 2016;37(4):E374-E379. | 0.00 | Y | 0.00000 | 20160907 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127220911 | 12722091 | 1 | PS | ASCORBIC ACID. | ASCORBIC ACID | 1 | Other | 66 MG/KG/HR | 224 | G | U | U | 0 | INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127220911 | 12722091 | 1 | Thermal burn |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127220911 | 12722091 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127220911 | 12722091 | Acute kidney injury | |
| 127220911 | 12722091 | Nephropathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |